The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...
The Food and Drug Administration (FDA) has approved Journavxâ„¢ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...
5d
StudyFinds on MSNJournavx: What to know about new FDA-approved non-opioid pain medicationIntroducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results